# IMMUNOVANT INC (IMVT)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/IMVT/

- Reporting holders: 5
- Reported value: $155.9M
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Two Seas Capital LP](https://holderbook.com/funds/1823138-two-seas-capital-lp/) | $155.8M | 4,612,692 | 1.8% | 13 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $83.6K | 2,475 | 0.0% | 12 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $41.3K | 1,224 | 0.0% | 12 |
| [MassMutual Private Wealth & Trust, FSB](https://holderbook.com/funds/1103653-massmutual-private-wealth-trust-fsb/) | $3.1K | 93 | 0.0% | 7 |
| [Trust Co](https://holderbook.com/funds/1632554-trust-co/) | $709 | 21 | 0.0% | 4 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 5 | $155.9M |
| Q2 2026 | 232 | $4.6B |
| Q1 2026 | 217 | $2.8B |
| Q4 2025 | 199 | $2.8B |
| Q3 2025 | 187 | $1.6B |
| Q2 2025 | 172 | $1.6B |
| Q1 2025 | 200 | $1.7B |
| Q4 2024 | 191 | $2.1B |
| Q3 2024 | 187 | $2.4B |
| Q2 2024 | 200 | $2.0B |
| Q1 2024 | 214 | $2.5B |
| Q4 2023 | 232 | $3.1B |